VWA
RIGL icon

Visionary Wealth Advisors’s Rigel Pharmaceuticals RIGL Stock Holding History

Visionary Wealth Advisors’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,230
Closed -$28.8K – 473
2023
Q2 		$28.8K Buy
2,230
+877
+65% +$11.9K ﹤0.01% 454
2023
Q1 		$17.9K Buy
+1,353
New +$21.5K ﹤0.01% 452
2022
Q1 		– Sell
-1,092
Closed -$29K – 451
2021
Q4 		$29K Sell
1,092
-25
-2% -$754 ﹤0.01% 381
2021
Q3 		$41K Sell
1,117
-52
-4% -$2.05K ﹤0.01% 309
2021
Q2 		$51K Buy
+1,169
New +$44.1K 0.01% 330

Other funds holding RIGL

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Visionary Wealth Advisors's RIGL Position: Q3 2023 in Review

Visionary Wealth Advisors sold out of Rigel Pharmaceuticals (RIGL) in Q3 2023, closing a stake of 2,230 shares — an estimated $28.8K sold.

Visionary Wealth Advisors first reported a position in RIGL in Q2 2021 and held it in 5 quarters. The position peaked at $51K in Q2 2021. 106 funds tracked by Wall St. Rank hold RIGL as of Q3 2023.

  • Visionary Wealth Advisors reported no remaining Rigel Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Visionary Wealth Advisors sold 2,230 Rigel Pharmaceuticals shares in Q3 2023, an estimated $28.8K.
  • Visionary Wealth Advisors first reported a position in Rigel Pharmaceuticals in Q2 2021 and held it in 5 quarters.
  • Visionary Wealth Advisors's Rigel Pharmaceuticals position peaked at $51K in Q2 2021.
  • 106 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2023.

Based on Visionary Wealth Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.